Cargando…
Multiparametric in vivo analyses of the brain and spine identify structural and metabolic biomarkers in men with adrenomyeloneuropathy
OBJECTIVE: Progressive myelopathy causes severe handicap in men with adrenomyeloneuropathy (AMN), an X-linked disorder due to ABCD1 pathogenic variants. At present, treatments are symptomatic but disease-modifying therapies are under evaluation. Given the small effect size of clinical scales in AMN,...
Autores principales: | Adanyeguh, Isaac M., Lou, Xiaofang, McGovern, Eavan, Luton, Marie-Pierre, Barbier, Magali, Yazbeck, Elise, Valabregue, Romain, Deelchand, Dinesh, Henry, Pierre-Gilles, Mochel, Fanny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847955/ https://www.ncbi.nlm.nih.gov/pubmed/33516063 http://dx.doi.org/10.1016/j.nicl.2021.102566 |
Ejemplares similares
-
Multiparametric characterization of white matter alterations in early stage Huntington disease
por: Adanyeguh, Isaac M., et al.
Publicado: (2021) -
Adrenomyeloneuropathy.
por: Dickey, W., et al.
Publicado: (1987) -
Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes
por: Adanyeguh, Isaac M., et al.
Publicado: (2018) -
Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy
por: Jønch, Aia Elise, et al.
Publicado: (2012) -
Adrenomyeloneuropathy Presenting With Adrenal Insufficiency
por: Park, Hee Dong, et al.
Publicado: (2013)